CHD8 |
- 3
Haplo
Score - 0
Triplo
Score
Gene Facts External Data Attribution
- HGNC Symbol
- CHD8 (HGNC:20153) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
- HGNC Name
- chromodomain helicase DNA binding protein 8
- Gene type
- protein-coding gene
- Locus type
- gene with protein product
- Previous symbols
- HELSNF1
- Alias symbols
- KIAA1564, DUPLIN
- %HI
- 11.24(Read more about the DECIPHER Haploinsufficiency Index)
- pLI
- 1(Read more about gnomAD pLI score)
- LOEUF
- 0.08(Read more about gnomAD LOEUF score)
- Cytoband
- 14q11.2
- Genomic Coordinates
-
GRCh37/hg19: chr14:21853358-21924282 NCBI Ensembl UCSC GRCh38/hg38: chr14:21385199-21456123 NCBI Ensembl UCSC - MANE Select Transcript
- NM_001170629.2 ENST00000646647.2 (Read more about MANE Select)
- Function
- DNA helicase that acts as a chromatin remodeling factor and regulates transcription. Acts as a transcription repressor by remodeling chromatin structure and recruiting histone H1 to target genes. Suppresses p53/TP53-mediated apoptosis by recruiting histone H1 and preventing p53/TP53 transactivation activity. Acts as a negative regulator of Wnt signaling pathway by regulating beta-catenin (CTNNB1) activity. Negatively regulates CTNNB1-targeted gene expression by being recruited specifically to th... (Source: Uniprot)
Dosage Sensitivity Summary (Gene)
Dosage ID:
ISCA-33618
Curation Status:
Complete
Issue Type:
Dosage Curation -
Gene
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency
(3)
Triplosensitivity:
No Evidence for Triplosensitivity
(0)
Related Links:
Last Evaluated:
04/25/2018
Haploinsufficiency (HI) Score Details
HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency
(Disclaimer)
HI Disease:
- complex neurodevelopmental disorder Monarch
HI Evidence:
-
PUBMED:
23160955
O'Roak et al. 2012 described nine de novo mutations in the CHD8 gene amongst 2,446 probands with autism spectrum disorder (ASD), where two cases were previously reported (patient# 13844.p1 and 12752.p1 in PMID: 22495309). The nine mutations included three nonsense (p.Ser62X, p.Gln1238X and p.Arg1337X), four frameshift (p.Tyr747X, p.Gln2103ArgfsX3, p.Leu2120ProfsX13 and p.Asn2371LysfsX2), one amino acid deletion (p.His2498del) and one intronic canonical splice site disruption (c.3519-2A>G).
-
PUBMED:
24998929
Bernier et al. (2014) reported twelve de novo truncating mutations in 3,730 children with developmental delay or ASD, where nine cases were previously reported by O'Roak et al. (2012). Apart from a diagnosis of ASD, the common features amongst reported patients included macrocephaly, prominent forehead, wide-set eyes, pointed chin as well as an increased rates of gastrointestinal (GI) complaints and marked sleep dysfunction. The three de novo mutations exclusively identified in this paper included one nonsense (p.Glu1114X) and two frameshift (p.Glu1932SerfsX3 and p.Glu2136ArgfsX6) mutations. Apart from the de novo mutations listed above, other reported cases included one frameshift mutation (p.Val984X) found to be maternally inherited, three missense mutations (p.Arg910Gln - unknown inheritance, p.Gly1710Val - maternally inherited, and p.Arg1797Gln - paternally inherited with similar phenotype), one case with 5-kp duplication found to be paternally inherited, and two cases with duplication of unknown inheritance. Functional studies with Chd8 knockdown in zebrafish recapitulates an overgrowth of the head (10-15% enlargement) and GI problems.
-
PUBMED:
27824329
Wang et al. (2016) studied 1,543 Chinese ASD probands and reported two de novo truncating mutations (p.Lys750Asnfs*14 and p.Arg1897Thrfs*23). The common phenotype included ASD, intellectual disability, developmental delay (motor and speech), repetitive behaviour, macrocephaly, attention problems, tall and overweight.
HI Evidence Comments:
Other papers with de novo mutations found in CHD8 gene included: [1]. McCarthy et al. (2014) reported a nonsense mutation (p.52173X) in a patient with ASD and schizophrenia (PMID: 24776741); [2]. Lee et al. (2014) described patient 97 (p.Arg773X) and patient 115 (p.Arg582X), where the common features included autism (PMID: 25326637); [3]. De Rubeis et al. (2014) reported two autistic patients with frameshift mutation (p.S1606RfsX8 and p.Y1642LfsX25) (PMID: 25363760).
Functional studies by Suetterlin et al. (2018) (PMID: 29668850) showed that the CHD8 protein levels were reduced by 51% in E12.5 neocortices of Chd8+/- mice validating CHD8 haploinsufficiency. There was no evidence of truncated protein products, which supported the nonsense-mediated decay event. Furthermore, the Chd8+/- mice showed a wider interorbital distance (i.e. hypertelomeric phenotype), an increase in the anterior-posterior length of the interparietal bone (i.e. craniofacial anomalies) and an increase of 2.7% in total brain volume. Evidence for delayed in motor development and hyperactivity was observed in the Chd8+/- pups, whilst adult Chd8+/- exhibited hypoactive phenotype. Notably, two independent experimental approaches at different time points identified specific axon guidance and cell adhesion genes that might be relevant in functional connectivity phenotype. Finally, the author concluded that the 'abnormalities in specific cortical-hippocampal circuits involved in sensory processing may underlie some of the unique anomalous behaviours observed in Chd8+/- mice, and by extension, the neuropsychiatric symptoms in patients with CHD8 haploinsufficiency'.
Another functional study by Gompers et al. (2017) (PMID: 28671691) showed that Chd8+/del5 mice with germline 5-bp and 14-bp deletion mutations in exon 5 of the CHD8 gene resulted in its loss-of-function. Overall, there was a link to cognitive deficits, increased regional brain volume and disruptions of the neurodevelopment biological pathways.
Triplosensitivity (TS) Score Details
TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
Genomic View
Select assembly:
(NC_000014.8)
(NC_000014.9)